SCHEMBL918486

SCHEMBL918486

CCC(SCC(=O)c1ccc(C)cc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
KMT2A Q03164 4/20 0.55
MAPT P10636 3/20 0.55
LMNA P02545 1/20 0.55
MEN1 O00255 2/20 0.49
ATM Q13315 1/20 0.49
HDAC3 O15379 6/20 0.49
HDAC4 P56524 6/20 0.49
HDAC1 Q13547 6/20 0.49
HDAC7 Q8WUI4 6/20 0.49
HDAC2 Q92769 6/20 0.49
HDAC10 Q969S8 6/20 0.49
HDAC11 Q96DB2 6/20 0.49
HDAC8 Q9BY41 6/20 0.49
HDAC6 Q9UBN7 6/20 0.49
HDAC9 Q9UKV0 6/20 0.49
HDAC5 Q9UQL6 6/20 0.49
POLB P06746 4/20 0.48
HTT P42858 2/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL918774 0.87 HDAC3 (0.49) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL919146 0.86 HDAC3 (0.50) ALDH1A1KMT2AMAPTLMNAHDAC3
SCHEMBL29217316 0.86 KMT2A (0.51) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL920192 0.83 HDAC3 (0.55) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL23879940 0.78 HDAC3 (0.61) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL2082472 0.75 HDAC3 (0.57) ALDH1A1KMT2AMAPTMEN1ATM
SCHEMBL19501967 0.73 HTT (0.72) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL10418143 0.71 HDAC3 (0.62) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL10917889 0.71 ALDH1A1 (0.72) ALDH1A1KMT2AMAPTLMNAMEN1
SCHEMBL6239079 0.70 HTT (0.40) ALDH1A1KMT2AMAPTMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7871998-B2 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity ASTRAZENECA AB (SE) 2011-01-18 US disclosed